Skip to main navigation Skip to search Skip to main content

The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation

  • T. Lion*
  • , F. Watzinger
  • , S. Preuner
  • , H. Kreyenberg
  • , M. Tilanus
  • , R. De Weger
  • , J. Van Loon
  • , L. De Vries
  • , H. Cavé
  • , C. Acquaviva
  • , M. Lawler
  • , M. Crampe
  • , A. Serra
  • , B. Saglio
  • , F. Colnaghi
  • , A. Biondi
  • , J. J.M. Van Dongen
  • , M. Van Der Burg
  • , M. Gonzalez
  • , M. Alcoceba
  • G. Barbany, M. Hermanson, E. Roosnek, C. Steward, J. Harvey, F. Frommlet, P. Bader
*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Hematopoietic stem cell transplantation is becoming an increasingly important approach to treatment of different malignant and non-malignant disorders. There is thus growing demand for diagnostic assays permitting the surveillance of donor/recipient chimerism posttransplant. Current techniques are heterogeneous, rendering uniform evaluation and comparison of diagnostic results between centers difficult. Leading laboratories from 10 European countries have therefore performed a collaborative study supported by a European grant, the EuroChimerism Concerted Action, with the aim to develop a standardized diagnostic methodology for the detection and monitoring of chimerism in patients undergoing allogeneic stem cell transplantation. Following extensive analysis of a large set of microsatellite/short tandem repeat (STR) loci, the EuroChimerism (EUC) panel comprising 13 STR markers was established with the aim to optimally meet the specific requirements of quantitative chimerism analysis. Based on highly stringent selection criteria, the EUC panel provides multiple informative markers in any transplant setting. The standardized STR-PCR tests permit detection of donor-or recipient-derived cells at a sensitivity ranging between 0.8 and 1.6%. Moreover, the EUC assay facilitates accurate and reproducible quantification of donor and recipient hematopoietic cells. Wide use of the European-harmonized protocol for chimerism analysis presented will provide a basis for optimal diagnostic support and timely treatment decisions.

Original languageEnglish
Pages (from-to)1821-1828
Number of pages8
JournalLeukemia
Volume26
Issue number8
DOIs
Publication statusPublished - Aug 2012

Bibliographical note

Funding Information:
We are grateful to the EU officers who have supervised and supported the project, including particularly Jaime Renart, Cornelius Schmaltz, Maria-José Vidal-Ragout and Micheline Divaris-Lambert. Moreover, we greatly appreciate the financial administrative help of Claudia Hochweis, Stefan Grünert, Alexandra Lidy and Karla Valdés-Rodriguez, the secretarial support of Ingrid Kerschberger and Nicole Reisinger at the coordinating center (CCRI) and the contributions of numerous technicians at the participating centers. The EuroChimerism Concerted Action (full project title: Diagnostic approaches to chimerism testing after allogeneic stem cell transplantation for early detection of graft rejection and relapse: technical development, standardization and European-coordinated clinical implementation) was carried out with financial support from the European commission within the call Quality of Life and Management of Living Resources, Fifth Framework Program, project No QLG1-CT-2002-01485.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • alleles
  • microsatellites
  • PCR
  • short tandem repeats

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation'. Together they form a unique fingerprint.

Cite this